Atherosclerosis and osteoporosis: age-dependent degenerative processes or related entities?

被引:144
作者
Anagnostis, P. [2 ]
Karagiannis, A. [2 ]
Kakafika, A. I. [2 ]
Tziomalos, K. [1 ]
Athyros, V. G. [2 ]
Mikhailidis, D. P. [1 ]
机构
[1] UCL, Dept Clin Biochem, Vasc Prevent Clin, London NW3 2QG, England
[2] Aristotle Univ Thessaloniki, Sch Med, Propedeut Dept Internal Med 2, GR-54006 Thessaloniki, Greece
关键词
Arterial calcification atherosclerosis; Biphosphonates; Fractures; Osteoporosis; Statins; BONE-MINERAL DENSITY; NF-KAPPA-B; CORONARY-HEART-DISEASE; POSTMENOPAUSAL WOMEN; VASCULAR CALCIFICATION; AORTIC CALCIFICATION; IN-VITRO; OSTEOBLAST DIFFERENTIATION; ADIPOGENIC DIFFERENTIATION; CARDIOVASCULAR-DISEASE;
D O I
10.1007/s00198-008-0648-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Osteoporosis and atherosclerosis, two multifactorial and degenerative entities, are major public health problems. These diseases accompany the aging process and share common risk factors. Furthermore, several common pathophysiological factors have been suggested. These include similar molecular pathways involving bone and vascular mineralization, estrogen deficiency, parathyroid hormone, homocysteine, lipid oxidation products, inflammatory process, as well as vitamin D and K. Moreover, the use of statins, biphosphonates, beta-blockers and experimental dual-purpose therapies based on the biological linkage of the above entities may simultaneously benefit bone loss and vascular disease. This review considers a potential link between osteoporosis and atherosclerosis beyond aging. These common factors may lead to appropriate treatment strategies.
引用
收藏
页码:197 / 207
页数:11
相关论文
共 117 条
[1]   Pleiotropic effects of statins and related pharmacological experimental approaches [J].
Alegret, M. ;
Silvestre, J. S. .
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2006, 28 (09) :627-656
[2]   Atorvastatin decreases triacylglycerol-associated risk of vascular events in coronary heart disease patients [J].
Athyros, Vasilios G. ;
Kakafika, Anna I. ;
Papageorgiou, Athanasios A. ;
Tziomalos, Konstantinos ;
Skaperdas, Athanasios ;
Pagourelias, Efstathios ;
Pirpasopoulou, Athina ;
Karagiannis, Asterios ;
Mikhailidis, Dimitri P. .
LIPIDS, 2007, 42 (11) :999-1009
[3]   Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J].
Baigent, C ;
Keech, A ;
Kearney, PM ;
Blackwell, L ;
Buck, G ;
Pollicino, C ;
Kirby, A ;
Sourjina, T ;
Peto, R ;
Collins, R ;
Simes, J .
LANCET, 2005, 366 (9493) :1267-1278
[4]  
Banerjee C, 1997, J CELL BIOCHEM, V66, P1, DOI 10.1002/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO
[5]  
2-V
[6]   Osteoporosis and coronary atherosclerosis in asymptomatic postmenopausal women [J].
Barengolts, EI ;
Berman, M ;
Kukreja, SC ;
Kouznetsova, T ;
Lin, C ;
Chomka, EV .
CALCIFIED TISSUE INTERNATIONAL, 1998, 62 (03) :209-213
[7]   Low levels of estradiol are associated with vertebral fractures in older men, but not women:: The Rancho Bernardo study [J].
Barrett-Connor, E ;
Mueller, JE ;
Von Mühlen, DG ;
Laughlin, GA ;
Schneider, DL ;
Sartoris, DJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (01) :219-223
[8]   Use of statins and fracture - Results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials [J].
Bauer, DC ;
Mundy, GR ;
Jamal, SA ;
Black, DM ;
Cauley, JA ;
Ensrud, KE ;
van der Klift, M ;
Pols, HAP .
ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (02) :146-152
[9]   TCF: transcriptional activator or repressor? [J].
Bienz, M .
CURRENT OPINION IN CELL BIOLOGY, 1998, 10 (03) :366-372
[10]   The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal [J].
Bolland, M. J. ;
Ames, R. W. ;
Horne, A. M. ;
Orr-Walker, B. J. ;
Gamble, G. D. ;
Reid, I. R. .
OSTEOPOROSIS INTERNATIONAL, 2007, 18 (04) :479-486